|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
74,175,000 |
Market
Cap: |
1.09(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$12.29 - $35.48 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 1065 |
Guru Rank Value : 0 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Pacira BioSciences is a holding company. Through its subsidiaries, Co. is focused on non-opioid pain management. Co. has three commercialized non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting, local analgesic approved for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular, corticosteroid injection indicated for the management of OA knee pain; and ioveradeg®, a handheld device for delivering immediate, long-acting, drug-free pain control using controlled doses of cold temperature to a targeted nerve.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
20,976 |
20,976 |
20,976 |
20,976 |
Total Buy Value |
$256,518 |
$256,518 |
$256,518 |
$256,518 |
Total People Bought |
5 |
5 |
5 |
5 |
Total Buy Transactions |
7 |
7 |
7 |
7 |
Total Shares Sold |
4,281 |
22,595 |
141,918 |
232,771 |
Total Sell Value |
$105,494 |
$627,547 |
$4,283,773 |
$7,829,365 |
Total People Sold |
2 |
5 |
6 |
15 |
Total Sell Transactions |
3 |
8 |
11 |
46 |
End Date |
2024-06-20 |
2024-03-19 |
2023-09-19 |
2022-09-19 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Hastings Paul J |
Director |
|
2014-10-10 |
4 |
AS |
$94.87 |
$237,175 |
D/D |
(2,500) |
853 |
|
- |
|
Hastings Paul J |
Director |
|
2014-10-10 |
4 |
OE |
$13.98 |
$34,950 |
D/D |
2,500 |
3,353 |
|
- |
|
Longenecker John P Phd |
Director |
|
2014-09-29 |
4 |
AS |
$96.40 |
$96,400 |
D/D |
(1,000) |
0 |
|
- |
|
Longenecker John P Phd |
Director |
|
2014-09-29 |
4 |
OE |
$29.90 |
$29,900 |
D/D |
1,000 |
1,000 |
|
- |
|
Wicki Andreas |
Director |
|
2014-08-29 |
4 |
S |
$108.15 |
$1,133,560 |
I/I |
(10,481) |
1,100,100 |
|
- |
|
Wicki Andreas |
Director |
|
2014-08-28 |
4 |
S |
$108.06 |
$1,190,097 |
I/I |
(11,013) |
1,110,581 |
|
- |
|
Wicki Andreas |
Director |
|
2014-08-27 |
4 |
S |
$108.05 |
$173,535 |
I/I |
(1,606) |
1,121,594 |
|
- |
|
Wicki Andreas |
Director |
|
2014-08-26 |
4 |
S |
$108.11 |
$2,617,016 |
I/I |
(24,207) |
1,123,200 |
|
- |
|
Wicki Andreas |
Director |
|
2014-08-25 |
4 |
S |
$108.07 |
$3,241,983 |
I/I |
(30,000) |
1,147,407 |
|
- |
|
Wicki Andreas |
Director |
|
2014-08-11 |
4 |
S |
$101.20 |
$6,894,905 |
I/I |
(67,900) |
1,177,407 |
|
- |
|
Wicki Andreas |
Director |
|
2014-08-08 |
4 |
S |
$101.00 |
$8,292,108 |
I/I |
(82,100) |
1,245,307 |
|
- |
|
Scibetta James S |
SVP, Chief Financial Officer |
|
2014-08-08 |
4 |
AS |
$99.22 |
$1,494,400 |
D/D |
(15,000) |
5,000 |
|
- |
|
Scibetta James S |
SVP, Chief Financial Officer |
|
2014-08-08 |
4 |
OE |
$1.61 |
$24,150 |
D/D |
15,000 |
20,000 |
|
- |
|
Patou Gary |
Chief Medical Officer |
|
2014-08-07 |
4 |
AS |
$100.26 |
$2,005,200 |
D/D |
(20,000) |
0 |
|
- |
|
Patou Gary |
Chief Medical Officer |
|
2014-08-07 |
4 |
OE |
$1.61 |
$203,258 |
D/D |
20,000 |
20,000 |
|
- |
|
Stack David M |
President, CEO and Chairman |
|
2014-07-15 |
4 |
AS |
$86.28 |
$1,301,232 |
D/D |
(15,000) |
1,208 |
|
- |
|
Stack David M |
President, CEO and Chairman |
|
2014-07-15 |
4 |
OE |
$1.61 |
$24,150 |
D/D |
15,000 |
16,208 |
|
- |
|
Patou Gary |
Chief Medical Officer |
|
2014-07-14 |
4 |
AS |
$86.91 |
$2,582,639 |
D/D |
(29,700) |
0 |
|
- |
|
Patou Gary |
Chief Medical Officer |
|
2014-07-14 |
4 |
OE |
$1.61 |
$194,007 |
D/D |
30,000 |
30,000 |
|
- |
|
Hastings Paul J |
Director |
|
2014-07-10 |
4 |
AS |
$82.46 |
$211,017 |
D/D |
(2,500) |
853 |
|
- |
|
Hastings Paul J |
Director |
|
2014-07-10 |
4 |
OE |
$13.98 |
$34,950 |
D/D |
2,500 |
3,353 |
|
- |
|
Longenecker John P Phd |
Director |
|
2014-06-30 |
4 |
AS |
$91.60 |
$91,600 |
D/D |
(1,000) |
0 |
|
- |
|
Longenecker John P Phd |
Director |
|
2014-06-30 |
4 |
OE |
$29.90 |
$29,900 |
D/D |
1,000 |
1,000 |
|
- |
|
Wicki Andreas |
Director |
|
2014-06-09 |
4 |
AS |
$84.55 |
$5,809,185 |
I/I |
(68,000) |
1,327,407 |
|
- |
|
Wicki Andreas |
Director |
|
2014-06-06 |
4 |
AS |
$82.71 |
$3,324,753 |
I/I |
(40,200) |
1,395,407 |
|
- |
|
276 Records found
|
|
Page 2 of 12 |
|
|